Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis

Area of Science:

• Pulmonary Medicine
• Immunogenetics
• Molecular Biology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive scarring, likely involving abnormal wound healing responses.
• Genetic factors and environmental exposures are suspected to influence IPF development and progression.
• Erythrocyte complement receptor 1 (CR1) plays a role in immune complex clearance, with gene polymorphisms affecting its surface density.

Purpose of the Study:

• To investigate the association between idiopathic pulmonary fibrosis (IPF) and specific genetic variations in the complement receptor 1 (CR1) gene.
• To determine if CR1 gene alleles associated with reduced CR1 molecule density on erythrocytes are more prevalent in IPF patients.

Main Methods:

• Genotyping analysis of three CR1 gene polymorphic sites (A3650G exon 22, HindIII RFLP intron 27, C5507G exon 33) in 74 IPF patients and 166 healthy controls.
• Assessment of linkage disequilibrium among the studied CR1 polymorphisms.
• Statistical analysis to compare genotype frequencies between IPF patients and controls.

Main Results:

• The three analyzed CR1 gene polymorphic sites were found to be in linkage disequilibrium.
• The GG genotype at the C5507G exon 33 polymorphism was significantly more frequent in IPF patients compared to controls (OR=6.232, p=0.00023).
• This association was observed in both male and female participants.

Conclusions:

• The study suggests a significant association between the complement receptor 1 (CR1) gene, specifically the C5507G exon 33 polymorphism, and idiopathic pulmonary fibrosis (IPF).
• Findings support the hypothesis that CR1 gene variations influencing immune complex clearance may contribute to IPF pathogenesis.
• Further research is warranted to elucidate the precise mechanisms linking CR1 gene alleles to IPF risk.